Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02905994
Title Volasertib Combined With Induction Chemotherapy in Acute Myeloid Leukemia
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Massachusetts General Hospital
Indications

acute myeloid leukemia

Therapies

Cytarabine + Idarubicin + Volasertib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.